Managing drug therapy-related problems and assessment of chronic diabetic wounds

Maria Infant Majula Shifani Mahendran,Vinoj Gopalakrishnan,Vaijayanthi Saravanan,Ramasamy Dhamodharan,Pradeep Jothimani,M. Balasubramanian,Abhimanyu Kumar Singh,Rajan Vaithianathan
DOI: https://doi.org/10.1080/03007995.2024.2414893
2024-11-02
Current Medical Research and Opinion
Abstract:Type 2 diabetes mellitus (T2DM), responsible for most diabetes cases recorded worldwide, increases the risk of chronic wounds and amputation. Patients with T2DM appear to be more susceptible to delayed wound healing due to their treatment adherence. This review explores the specifics of polypharmacy, side effects, possible drug interactions and the importance of medication adherence for therapeutic efficacy. We discuss the effects of anti-diabetes medications on wound healing as well as the role that biofilms and microbial infections play in diabetic wounds. Inconsistent use of medications can lead to poor glycaemic control, which negatively affects the healing process of diabetic foot ulcers. Managing chronic wounds represents a substantial portion of healthcare expenditures. Biofilm-associated infections are difficult for the immune system to treat and respond inconsistently to antibiotics as these infections are slow growing and persistent. Additionally, we emphasize the critical role pharmacists play in enhancing patient adherence and optimizing diabetes treatment by offering comprehensive coverage of drugs associated with problems related to pharmacological therapy in type 2 diabetes.
medicine, general & internal, research & experimental
What problem does this paper attempt to address?